Tumor cells overexpressing MYC, such as non-Hodgkin lymphoma (NHL) cells, rely on glutamine metabolism as a fuel for the TCA cycle in the tumor microenvironment with its specific nutrient supply [38]. The gene discussed is MYC; the disease is neoplasm.